Some studies have suggested that overexpression of METTL3 profoundly inhibited the proliferation, tumorigenicity and migration ability of glioma [144, 145], breast cancer [146] or bladder cancer cells [147] by altering the mRNA expression of genes or proteins. This evidence concerns the gene METTL3 and central nervous system cancer.